Skip to content

Investors

Investors

Investors

Welcome to our Investor Center. Our center is designed to provide you with convenient access to company information. For additional information on our portfolio of product candidates, please visit Pipeline.
 

Webcasts
More>>
Webcast ImageWebcast (Replay)
ACADIA Pharmaceuticals at JMP Securities Healthcare Conference
06/24/14 at 1:30 p.m. ET
ACADIA Pharmaceuticals at JMP Securities Healthcare Conference
Tuesday, June 24, 2014 1:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast (Replay)
ACADIA Pharmaceuticals - An Educational Program on Parkinson’s Disease Psychosis
05/22/12 at 12:00 p.m. ET
ACADIA Pharmaceuticals - An Educational Program on Parkinson’s Disease Psychosis
Tuesday, May 22, 2012 12:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
 

Recent News
More>>
DateTitle 
08/28/14ACADIA Pharmaceuticals Announces Trade Name NUPLAZID™ for Pimavanserin
SAN DIEGO--(BUSINESS WIRE)--Aug. 28, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous disorders, today announced that the U.S. Food and Drug Administration (FDA) has provisionally accepted the trade name “NUPLAZID”™ for pimavanserin. NUPLAZID is a selective serotonin inverse ... 
Printer Friendly Version
08/05/14ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Aug. 5, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the second quarter ended June 30, 2014. ACADIA reported a net loss of $21.5 million, or $0.22 per common share, ... 
Printer Friendly Version
07/29/14ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014
ACADIA to Host Conference Call and Webcast on Tuesday, August 5, 2014, at 5:00 p.m. Eastern Time SAN DIEGO--(BUSINESS WIRE)--Jul. 29, 2014-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its unaudited financia... 
Printer Friendly Version
 

Stock Quote
More>>
ACAD (common stock)
ExchangeNASDAQ
Price$23.98
Change (%) Stock is Up 0.37 (1.57%)
Volume636,507
08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
Minimum 20 minutes delayed
Stay Informed
Corporate Presentation
Request Literature
Scientific Publications
Subscribe to Email Alerts
RSS Feeds
IR Contact
Featured Reports
Lancet Article on Pimavanserin Phase III PDP Trial
Annual Report
Proxy Statement
Parkinson’s Disease Psychosis Backgrounder
back to top